AU2002340850A1 - Antigen mimotopes and vaccine against cancers - Google Patents

Antigen mimotopes and vaccine against cancers

Info

Publication number
AU2002340850A1
AU2002340850A1 AU2002340850A AU2002340850A AU2002340850A1 AU 2002340850 A1 AU2002340850 A1 AU 2002340850A1 AU 2002340850 A AU2002340850 A AU 2002340850A AU 2002340850 A AU2002340850 A AU 2002340850A AU 2002340850 A1 AU2002340850 A1 AU 2002340850A1
Authority
AU
Australia
Prior art keywords
vaccine against
against cancers
antigen mimotopes
mimotopes
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002340850A
Other versions
AU2002340850B2 (en
Inventor
Heimo Breiteneder
Erika Jensen-Jarolim
Hubert Pehamberger
Otto Scheiner
Christoph Zielinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Life Science Forschungs-Und Entwicklungsgesmbh
Original Assignee
Bio Life Science Forschungs-Und Entwicklungsgesmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01121105A external-priority patent/EP1287831B1/en
Application filed by Bio Life Science Forschungs-Und Entwicklungsgesmbh filed Critical Bio Life Science Forschungs-Und Entwicklungsgesmbh
Publication of AU2002340850A1 publication Critical patent/AU2002340850A1/en
Assigned to BIO LIFE SCIENCE FORSCHUNGS-UND ENTWICKLUNGSGES.M.B.H. reassignment BIO LIFE SCIENCE FORSCHUNGS-UND ENTWICKLUNGSGES.M.B.H. Amend patent request/document other than specification (104) Assignors: BIO LIFE SCIENCE FORSCHUNGS-UND ENTWICKLUNGSGES.M.B.H.
Application granted granted Critical
Publication of AU2002340850B2 publication Critical patent/AU2002340850B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002340850A 2001-09-03 2002-09-02 Antigen mimotopes and vaccine against cancers Ceased AU2002340850B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01121105A EP1287831B1 (en) 2001-09-03 2001-09-03 Antigen mimotopes and vaccine against cancerous diseases
EP01121105.9 2001-09-03
PCT/EP2002/009790 WO2003020750A2 (en) 2001-09-03 2002-09-02 Antigen mimotopes and vaccine against cancers

Publications (2)

Publication Number Publication Date
AU2002340850A1 true AU2002340850A1 (en) 2003-06-05
AU2002340850B2 AU2002340850B2 (en) 2008-07-10

Family

ID=8178524

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002340850A Ceased AU2002340850B2 (en) 2001-09-03 2002-09-02 Antigen mimotopes and vaccine against cancers

Country Status (9)

Country Link
US (1) US20050106158A1 (en)
EP (1) EP1287831B1 (en)
AT (1) ATE345812T1 (en)
AU (1) AU2002340850B2 (en)
CA (1) CA2458538A1 (en)
DE (1) DE50111493D1 (en)
ES (1) ES2276732T3 (en)
IL (2) IL160387A0 (en)
WO (1) WO2003020750A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT413945B (en) 2003-01-14 2006-07-15 Mattner Frank Dr Use of a compound having a binding capacity to an antibody specific for the natural N-terminal AB42 sequence, for preparing a vaccine for preventing and treating Alzheimer's disease
AT500835B1 (en) * 2004-09-13 2007-12-15 Affiris Forschungs & Entwicklungs Gmbh CHOLINESTERTRANSPORT PROTEIN MIMOTOP AS ATHEROSCLEROSIS MEDICAMENT
PT2758433T (en) 2011-09-19 2018-01-19 Axon Neuroscience Se Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
US20150056209A1 (en) * 2012-04-18 2015-02-26 The Regents Of The University Of California Peptide mimotopes to oxidation specific epitopes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006692A1 (en) * 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
NZ229159A (en) * 1988-05-17 1992-11-25 Soldano Ferrone Anti-idiotype antibodies which bind to the idiotype of murine antibody 225.28
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5869445A (en) * 1993-03-17 1999-02-09 University Of Washington Methods for eliciting or enhancing reactivity to HER-2/neu protein
AU2016199A (en) * 1998-12-24 2000-07-31 New York Medical College Peptide mimics useful for treating disease
AU8024100A (en) * 1999-10-13 2001-04-23 Roswell Park Memorial Institute Induction of a strong immune response to a self-tumor associated antigen

Similar Documents

Publication Publication Date Title
AU2001252458A1 (en) Molecular antigen arrays and vaccines
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2002351623A1 (en) Streptococcus antigens
AU2002244968A1 (en) Anti-osteopontin antibody and use thereof
AUPR395801A0 (en) Antibodies against cancer
IL206832A0 (en) Antibodies binding an 161p2f10b epitope and uses thereof
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
AU2003262094A1 (en) Cancer antigen peptide preparation
AU2001290860A1 (en) Spas-1 cancer antigen
AU2002326751A1 (en) Immunoglobulin e vaccines and methods of use thereof
GB0126378D0 (en) Antigen
AU2002361559A1 (en) Anticancer vaccine and diganostic methods and reagents
AU2002349543A1 (en) Tumor antigens
AU2002365228A1 (en) Antigen panels and methods of using the same
AU2002307438A1 (en) Cancer-testis antigens
AU2002243314A1 (en) Immunogenic cancer peptides and uses thereof
GB0114517D0 (en) Trx1 antibody and uses therefor
EP1316560A4 (en) Novel human cancer/testis antigen and gene thereof
AU2003267361A1 (en) Orthopoxvirus antigens and use thereof
AU2002340850A1 (en) Antigen mimotopes and vaccine against cancers
AU2002227272A1 (en) Ovarian tumor antigen and methods of use therefor
AU2001261534A1 (en) The meca-79 antigen and related methods
EP1403283A4 (en) Tumor antigen
AU2001253852A1 (en) Preprocalcitonin as tumor rejection antigen precursor and uses thereof
AU5632500A (en) Cancer associated antigens and uses therefor